This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Oct;97(19):1537-9.

doi: 10.1136/heartjnl-2011-300411.

Erythropoietin as a cardioprotective agent: down but not out

PMID: 21900581
DOI: 10.1136/heartjnl-2011-300411

Editorial

Erythropoietin as a cardioprotective agent: down but not out

Lionel H Opie. Heart. 2011 Oct.

. 2011 Oct;97(19):1537-9.

doi: 10.1136/heartjnl-2011-300411.

Author

PMID: 21900581
DOI: 10.1136/heartjnl-2011-300411

No abstract available

PubMed Disclaimer

Comment on

Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial.
Ludman AJ, Yellon DM, Hasleton J, Ariti C, Babu GG, Boston-Griffiths E, Venugopal V, Walker M, Holdright D, Swanton H, Crake T, Brull D, Moon JC, Puranik R, Muthurangu V, Taylor A, Hausenloy DJ. Ludman AJ, et al. Heart. 2011 Oct;97(19):1560-5. doi: 10.1136/hrt.2011.223867. Heart. 2011. PMID: 21900585 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information